(Q45147293)

10 December 2017

1 reference

title

Schizophrenia, diabetes mellitus and antipsychotics (English)

1 reference

10 December 2017

1 reference

Gury C

1

1 reference

10 December 2017

publication date

1 July 2004

1 reference

L'Encephale: revue de psychiatrie clinique biologique et therapeutique

10 December 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

10 December 2017

volume

30

1 reference

10 December 2017

issue

4

1 reference

10 December 2017

page(s)

382-391

1 reference

The distribution of body mass index among individuals with and without schizophrenia.

10 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Dexamethasone suppression test in positive and negative schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

The effects of metabolic stress on plasma progesterone in healthy volunteers and schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

The unhealthy lifestyle of people with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Physical health of the long-term mentally ill in the community. Is there unmet need?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Effects of chlorpromazine on plasma glucose kinetics and concentration of long chain fatty acids in sheep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and alpha 1-adrenergic receptors in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Raised plasma cortisol concentrations a feature of drug-free psychotics and not specific for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Abnormal dexamethasone suppression test results in chronic schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Prevalence and correlates of diabetes in national schizophrenia samples.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Depression and risk for onset of type II diabetes. A prospective population-based study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Effect of acute metabolic stress on pituitary-adrenal axis activation in patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Effect of chlorpromazine on blood glucose and plasma insulin in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Chlorpromazine in the treatment of endogenous organic hyperinsulinism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Diurnal rhythm of plasma beta endorphin, cortisol and growth hormone in schizophrenics as compared to control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

New-onset diabetes mellitus and diabetic ketoacidosis associated with olanzapine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Severe hyperglycemia associated with high doses of clozapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Hypothalamic-pituitary-adrenal axis function in chronic schizophrenia: association with clinical features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Cardiovascular and respiratory risk factors and symptoms among general practice patients with long-term mental illness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Ketoacidosis as a side-effect of clozapine: a case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Diabetic ketoacidosis associated with clozapine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Chlorpromazine in malignant insulinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Prevalence of diabetes in a manic-depressive population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Atypical antipsychotics and hyperglycaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Diabetes mellitus in schizophrenic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Effects of alpha- and beta-adrenergic blockers on chlorpromazine-induced elevation of plasma glucose and cyclic AMP in fed mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Diabetic ketoacidosis from clozapine and lithium cotreatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Clozapine and associated diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

The interactions between hypothalamic-pituitary-adrenal axis activity, testosterone, insulin-like growth factor I and abdominal obesity with metabolism and blood pressure in men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Atypical antipsychotics and weight gain--a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Phenothiazines and Diabetes in Hospitalized Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Circadian and Sleep-Related Endocrine Rhythms in Schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

A Survey for Unknown Diabetics in a Mental Hospital: I. Men under Age Fifty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Centrally mediated drug-induced hyperglycemia in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

Novel antipsychotics and new onset diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0013-7006%2804%2995452-8

10.1016/S0013-7006(04)95452-8

7 January 2021

Identifiers

DOI

1 reference

10 December 2017

1 reference